bf/NYSE:LLY_icon.png

NYSE:LLY

Eli Lilly and Company

  • Stock

794.10

−11.66%

−18.59

USD last updated 26/07 01:59:53

Last Close

812.69

25/07 22:30

Market Cap

893.17B

Beta: 0.36

Volume Today

11.69M

Avg: 3.30M

PE Ratio

127.25

PFCF: −4,061.24

Dividend Yield

0.64%

Payout:78.90%

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    123452017-07-252019-07-302021-08-032023-08-082024-10-30

    Revenue (Estimate*)

    2B4B6B8B10B12B14B2017-07-252019-07-302021-08-032023-08-082024-10-30

    *Estimate based on analyst consensus